ATE88188T1 - Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist. - Google Patents

Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist.

Info

Publication number: ATE88188T1
Authority: AT; Austria
Prior art keywords: factor; preparation; high purity; antihaemophilic; exhibiting high
Prior art date: 1989-02-17

Application number

AT90400203T

Other languages

English (en)

Inventor

Bernard Jules Dazey

Mohamed Hamsany

Gerard Paul Vezon

Original Assignee

Aquitaine Dev Transf Sanguine

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-02-17

Filing date

1990-01-24

Publication date

1993-04-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9378912&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE88188(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1990-01-24 Application filed by Aquitaine Dev Transf Sanguine filed Critical Aquitaine Dev Transf Sanguine

1993-04-15 Application granted granted Critical

1993-04-15 Publication of ATE88188T1 publication Critical patent/ATE88188T1/de

Links

102100026735 Coagulation factor VIII Human genes 0.000 title 1
101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 title 1
230000001747 exhibiting effect Effects 0.000 title 1
229960000301 factor viii Drugs 0.000 title 1
230000000603 anti-haemophilic effect Effects 0.000 abstract 5
238000004519 manufacturing process Methods 0.000 abstract 2
108010047303 von Willebrand Factor Proteins 0.000 abstract 2
102100036537 von Willebrand factor Human genes 0.000 abstract 2
229960001134 von willebrand factor Drugs 0.000 abstract 2
238000004587 chromatography analysis Methods 0.000 abstract 1
238000003795 desorption Methods 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
238000004255 ion exchange chromatography Methods 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
238000000746 purification Methods 0.000 abstract 1
238000001179 sorption measurement Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Gastroenterology & Hepatology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Toxicology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Biophysics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)

AT90400203T 1989-02-17 1990-01-24 Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist. ATE88188T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR8902136A FR2644064B1 (fr)	1989-02-17	1989-02-17	Procede de fabrication du facteur antihemophilique fviiic ayant une tres haute purete et facteur antihemophilique fviiic ainsi obtenu, ainsi que composition pharmaceutique le contenant

Publications (1)

Publication Number	Publication Date
ATE88188T1 true ATE88188T1 (de)	1993-04-15

Family

ID=9378912

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90400203T ATE88188T1 (de)	1989-02-17	1990-01-24	Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist.

Country Status (7)

Country	Link
EP (1)	EP0383645B1 (de)
JP (1)	JP2521551B2 (de)
AT (1)	ATE88188T1 (de)
DE (1)	DE69001309T2 (de)
DK (1)	DK0383645T3 (de)
ES (1)	ES2055875T3 (de)
FR (1)	FR2644064B1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5760183A (en) *	1989-02-17	1998-06-02	Association D'aquitaine Pour De Developpment De La Transfusion Sanguine Et Des Recherches Hematologiques	Process for the manufacture of very high-purity antithaemophilic factor (FVIIIC), and von Willebrand factor, and pharmaceutical compositions containing same
FR2665449B1 (fr) *	1990-08-02	1995-04-14	Aquitaine Developp Transf Sang	Procede de fabrication de facteur von willebrand ayant une tres haute purete, depourvu en majeure partie de facteur antihemophilique (fviiic), et facteur von willebrand ainsi obtenu, ainsi qu'une composition pharmaceutique le contenant.
IT1248723B (it) *	1990-06-12	1995-01-26	Scalvo S P A	Processo per la purificazione del fattore viii e fattore viii ottenuto con tale processo
DE4111393A1 (de) *	1991-04-09	1992-10-15	Behringwerke Ag	Stabilisierte faktor viii-praeparationen
FR2686883B1 (fr) *	1992-02-04	1994-05-13	Aquitaine Develop Transf Sanguin	Procede de fabrication de fibrinogene de tres haute purete, fibrinogene de tres haute purete obtenu ainsi qu'une composition pharmaceutique le contenant.
FR2772381B1 (fr) *	1997-12-15	2001-06-08	Lab Francais Du Fractionnement	Procede de preparation par filtration d'une solution de facteur viii securisee viralement

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4361509A (en) *	1981-12-14	1982-11-30	Scripps Clinic And Research Foundation	Ultrapurification of factor VIII using monoclonal antibodies
US4495175A (en) *	1982-08-05	1985-01-22	University Of Rochester	Preparation of highly purified human antihemophilic factor
US4508709A (en) *	1983-12-05	1985-04-02	Armour Pharmaceutical Company	Process for purifying factor VIII:C
US4743680A (en) *	1985-02-01	1988-05-10	New York University	Method for purifying antihemophilic factor
NL8701915A (nl) *	1987-08-14	1989-03-01	Waander Riethorst	Adsorbensmateriaal en toepassing daarvan voor het isoleren van stollingsfaktoren.
FR2632309B1 (fr) *	1988-06-07	1990-08-24	Lille Transfusion Sanguine	Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
DE3904354A1 (de) *	1989-02-14	1990-08-16	Behringwerke Ag	Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung

1989
- 1989-02-17 FR FR8902136A patent/FR2644064B1/fr not_active Expired - Lifetime
1990
- 1990-01-24 DE DE9090400203T patent/DE69001309T2/de not_active Expired - Fee Related
- 1990-01-24 EP EP90400203A patent/EP0383645B1/de not_active Expired - Lifetime
- 1990-01-24 ES ES90400203T patent/ES2055875T3/es not_active Expired - Lifetime
- 1990-01-24 AT AT90400203T patent/ATE88188T1/de not_active IP Right Cessation
- 1990-01-24 DK DK90400203.7T patent/DK0383645T3/da active
- 1990-02-17 JP JP2037113A patent/JP2521551B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JP2521551B2 (ja)	1996-08-07
JPH02282400A (ja)	1990-11-19
EP0383645A1 (de)	1990-08-22
DE69001309T2 (de)	1993-08-05
DE69001309D1 (de)	1993-05-19
ES2055875T3 (es)	1994-09-01
FR2644064B1 (fr)	1994-05-27
FR2644064A1 (fr)	1990-09-14
EP0383645B1 (de)	1993-04-14
DK0383645T3 (da)	1993-08-02

Legal Events

Date	Code	Title	Description
2009-10-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
IE860305L (en)	1986-08-01	Method for purifying antihemophilic factor
DE60014047D1 (de)	2004-10-28	Verfahren zur reinigung von milchsäure auf industrieller basis
LV10053A (lv)	1994-05-10	Kompleksa "Faktors-YIII + fon Villebranda faktors" koncentrata iegusanas metode
ATE87006T1 (de)	1993-04-15	Peptidderivate, verfahren zu ihrer herstellung und ihre verwendung.
FI902017A0 (fi)	1990-04-23	Foerfarande foer rengoering av protein.
DE3886237D1 (de)	1994-01-27	Reinigung von LFA-3.
ATE131490T1 (de)	1995-12-15	Verfahren zur herstellung von gereinigten albuminlösungen
DE69125764D1 (de)	1997-05-28	Verfahren zur Herstellung des Von Willebrand-Faktors von höchster Reinheit
ATE166881T1 (de)	1998-06-15	Verfahren zur herstellung von faktor viii
DE69001309D1 (de)	1993-05-19	Verfahren zur herstellung von antihaemophilem faktor (faktor viii), der eine hohe reinheit aufweist.
EP0317627A4 (en)	1990-12-12	Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof
ES2125938T3 (es)	1999-03-16	Procedimiento para la reactivacion de proteinas membranales purificadas.
DE69411492D1 (de)	1998-08-13	Verfahren zur Reinigung von mittleren Olefinen
ATE116636T1 (de)	1995-01-15	Verfahren zur herstellung von 2,6- dichlordiphenylaminessigsäurederivaten.
IT1222427B (it)	1990-09-05	Procedimento per la purificazione di interferone
EP0233620A3 (en)	1988-02-03	Adsorbent for purification of blood coagulation factor viii and process for purification of blood coagulation factor viii using the same
DE69026912D1 (de)	1996-06-13	Verfahren zur Herstellung von Nojirimycin-Verbindungen
DE68918436D1 (de)	1994-10-27	Adsorptives Trennungsverfahren zur Reinigung von 2,6-Dimethylnaphthalin.
ES8206549A1 (es)	1982-08-16	Procedimiento para la preparacion de nuevos analogos utiles de lincomicina y clindamicina.